Nadia Altomare

Nadia Altomare is the Chief Commercial Officer of Sera Prognostics Inc., a global leader in high-value women’s health diagnostics. She is focused on its breakthrough diagnostics product where she is leading the commercial business strategy and implementing the building blocks for widespread payer coverage. Previously, as President and then CEO at Abcodia Ltd, a clinical-stage company engaged in using human serum-based biomarkers to develop validated tests for the early detection of cancer, Nadia set up the U.S. subsidiary and oversaw the subsequent launch of global commercial operations. Prior to Abcodia, Nadia was Vice President & General Manager at ThermoFisher Scientific, a multinational biotechnology product development company. Her early career was spent through a series mergers and acquisitions and an IPO, resulting in a company ultimately acquired by PerkinElmer. Among her accomplishments was the startup, build and scale of the ViaCord division. Nadia received an MBA from Northeastern University and a BS in Business Administration from SUNY Stony Bro